SG
Sector Gamma As
13F filer · CIK 0001475373Reported Aug 12, 2026
Net seller this quarter
13F portfolio value$461MU.S. long equity reported on 13F
Positions406 new · 8 closed
Net flow last quarter-$3.59MBuys minus sells
Top 10 positions weight48.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 12, 202640 positions | |||||
| $41.8M | 9.08% | 0.04% | -12.3% | Q2 2014 | |
| $27.9M | 6.05% | 0.01% | -16.6% | Q1 2016 | |
| $27.6M | 5.98% | 0.03% | +25.6% | Q2 2020 | |
| $24.2M | 5.25% | 0.02% | -8.0% | Q4 2020 | |
| $19.4M | 4.20% | 0.09% | -14.8% | Q3 2018 | |
| $17.2M | 3.73% | 0.02% | +1.2% | Q2 2016 | |
| $16.9M | 3.66% | 0.15% | +22.9% | Q4 2019 | |
| $16.8M | 3.65% | 0.01% | Not reported | Q2 2013 | |
| $16.1M | 3.49% | 0.01% | +14.8% | Q4 2018 | |
| $15.1M | 3.27% | 0.05% | +93.8% | Q1 2026 | |
| $15M | 3.26% | 0.11% | +11.8% | Q4 2017 | |
| $14.1M | 3.06% | 0.03% | +12.8% | Q4 2020 | |
| $13.4M | 2.90% | 0.01% | +68.5% | Q2 2016 | |
| $13.3M | 2.89% | 0.05% | +64.4% | Q2 2023 | |
| $12.3M | 2.66% | 0.07% | -8.7% | Q1 2022 | |
| $11.7M | 2.54% | 0.04% | -39.9% | Q4 2013 | |
| $11.2M | 2.44% | 0.13% | +77.2% | Q4 2018 | |
| $10.4M | 2.26% | 0.03% | Not reported | Q4 2020 | |
| $9.84M | 2.13% | 0.02% | Not reported | Q2 2018 | |
| $9.79M | 2.12% | 0.12% | +40.4% | Q2 2013 | |
| $9.67M | 2.10% | 0.02% | -25.9% | Q2 2013 | |
| $9.52M | 2.06% | 0.00% | -44.3% | Q2 2024 | |
| $9.17M | 1.99% | 0.10% | -40.0% | Q2 2019 | |
| $8.97M | 1.95% | 0.13% | +30.3% | Q2 2025 | |
| $8.16M | 1.77% | 0.12% | +33.3% | Q1 2019 | |
| $7.29M | 1.58% | 0.03% | +36.8% | Q2 2025 | |
| $6.88M | 1.49% | 0.03% | +82.0% | Q2 2025 | |
| $5.68M | 1.23% | 0.03% | Not reported | Q1 2025 | |
| $5.46M | 1.19% | 0.01% | Not reported | Q3 2013 | |
| $5.28M | 1.15% | 0.27% | -15.5% | Q3 2025 | |
| $5.17M | 1.12% | 0.01% | Not reported | Q2 2013 | |
| $4.75M | 1.03% | 0.49% | +5.2% | Q3 2025 | |
| $4.54M | 0.99% | 0.08% | New | Q2 2026 | |
| CPCRNXCrinetics Pharmaceuticals, Inc. | $4.29M | 0.93% | 0.11% | +21.7% | Q4 2025 |
| $4.03M | 0.87% | 0.38% | Not reported | Q1 2025 | |
| $4.03M | 0.87% | 0.21% | +7.6% | Q1 2026 | |
| $3.83M | 0.83% | 0.04% | New | Q2 2026 | |
| $3.67M | 0.80% | 0.10% | -28.0% | Q2 2021 | |
| $3.5M | 0.76% | 0.28% | +33.1% | Q1 2026 | |
| $3.13M | 0.68% | 0.13% | New | Q2 2026 | |
| Q1 2026Reported May 7, 202642 positions | |||||
| $50.2M | 11.86% | 0.04% | +11.0% | Q2 2014 | |
| $31.3M | 7.39% | 0.01% | -28.4% | Q1 2016 | |
| $30.6M | 7.24% | 0.02% | +27.0% | Q4 2020 | |
| $24.3M | 5.74% | 0.02% | +4.1% | Q2 2020 | |
| $18.9M | 4.46% | 0.10% | -8.4% | Q3 2018 | |
| $16.6M | 3.92% | 0.01% | -22.6% | Q2 2024 | |
| $16.5M | 3.90% | 0.06% | +5.4% | Q4 2013 | |
| $14.1M | 3.33% | 0.08% | +17.6% | Q1 2022 | |
| $13.6M | 3.20% | 0.12% | +20.9% | Q4 2019 | |
| $13M | 3.07% | 0.03% | -37.6% | Q4 2020 | |
| $12.9M | 3.04% | 0.02% | +35.1% | Q2 2016 | |
| $12.7M | 3.00% | 0.10% | -8.4% | Q4 2017 | |
| $11.6M | 2.74% | 0.02% | -11.4% | Q2 2013 | |
| $9.86M | 2.33% | 0.00% | Not reported | Q2 2013 | |
| $9.72M | 2.30% | 0.01% | -23.8% | Q4 2018 | |
| $9.17M | 2.17% | 0.17% | -0.3% | Q2 2019 | |
| $9M | 2.12% | 0.03% | +10.5% | Q2 2023 | |
| $8.99M | 2.12% | 0.01% | Not reported | Q2 2016 | |
| $7.42M | 1.75% | 0.00% | -69.8% | Q3 2016 | |
| $7.08M | 1.67% | 0.14% | -0.5% | Q2 2023 | |
| $6.86M | 1.62% | 0.02% | New | Q1 2026 | |
| $6.68M | 1.58% | 0.32% | +13.5% | Q3 2025 | |
| $6.62M | 1.56% | 0.09% | Not reported | Q2 2013 | |
| $6.5M | 1.54% | 0.07% | Not reported | Q4 2018 | |
| $5.45M | 1.29% | 0.10% | Not reported | Q2 2025 | |
| $5.32M | 1.26% | 0.03% | -37.1% | Q4 2020 | |
| $5.12M | 1.21% | 0.39% | Not reported | Q1 2025 | |
| $5.11M | 1.21% | 0.09% | +21.1% | Q1 2019 | |
| $5.07M | 1.20% | 0.02% | -29.6% | Q2 2025 | |
| $4.87M | 1.15% | 0.03% | +30.7% | Q1 2025 | |
| $4.84M | 1.14% | 0.01% | -37.3% | Q3 2013 | |
| $3.52M | 0.83% | 0.01% | -26.3% | Q2 2025 | |
| CPCRNXCrinetics Pharmaceuticals, Inc. | $3.42M | 0.81% | 0.09% | -18.1% | Q4 2025 |
| $3.35M | 0.79% | 0.46% | -9.7% | Q3 2025 | |
| $3.33M | 0.79% | 0.02% | Not reported | Q2 2019 | |
| $3.29M | 0.78% | 0.02% | New | Q1 2026 | |
| $3.16M | 0.75% | 0.21% | New | Q1 2026 | |
| $3.12M | 0.74% | 0.10% | New | Q1 2026 | |
| $3.09M | 0.73% | 0.21% | New | Q1 2026 | |
| $3.08M | 0.73% | 0.05% | New | Q1 2026 | |
| $2.25M | 0.53% | 0.14% | +25.3% | Q2 2021 | |
| $1.88M | 0.44% | 0.02% | New | Q1 2026 | |
| Q4 2025Reported Feb 12, 202636 positions | |||||
| $40.2M | 9.17% | 0.04% | +28.3% | Q2 2014 | |
| $38.3M | 8.73% | 0.01% | +12.8% | Q1 2016 | |
| $25.9M | 5.90% | 0.02% | -11.1% | Q2 2020 | |
| $25.7M | 5.86% | 0.05% | +21.6% | Q4 2020 | |
| $21.7M | 4.94% | 0.01% | +19.8% | Q3 2016 | |
| $21.6M | 4.93% | 0.11% | +6.7% | Q3 2018 | |
| $21.4M | 4.88% | 0.02% | -31.4% | Q4 2020 | |
| $20M | 4.55% | 0.01% | -0.8% | Q2 2024 | |
| $15M | 3.43% | 0.06% | +13.3% | Q4 2013 | |
| $14.6M | 3.34% | 0.11% | -31.7% | Q4 2017 | |
| $14.1M | 3.21% | 0.01% | +13.7% | Q4 2018 | |
| $12.7M | 2.90% | 0.03% | +4.1% | Q2 2013 | |
| $12.6M | 2.86% | 0.01% | +17.6% | Q2 2013 | |
| $12M | 2.73% | 0.17% | +1.5% | Q2 2019 | |
| $11.9M | 2.72% | 0.07% | +16.7% | Q1 2022 | |
| $11.8M | 2.69% | 0.10% | +12.9% | Q4 2019 | |
| $11.4M | 2.60% | 0.01% | +238.9% | Q2 2016 | |
| $10.6M | 2.42% | 0.05% | +21.1% | Q4 2020 | |
| $9.38M | 2.14% | 0.03% | +2.7% | Q2 2023 | |
| $8.22M | 1.87% | 0.02% | +32.1% | Q3 2013 | |
| $7.97M | 1.82% | 0.10% | +45.8% | Q2 2025 | |
| $7.2M | 1.64% | 0.09% | +4.0% | Q2 2013 | |
| $6.78M | 1.55% | 0.03% | +4.0% | Q2 2025 | |
| $6.24M | 1.42% | 0.15% | +45.7% | Q2 2023 | |
| $5.87M | 1.34% | 0.39% | -0.9% | Q1 2025 | |
| $5.53M | 1.26% | 0.01% | Not reported | Q2 2018 | |
| CPCRNXCrinetics Pharmaceuticals, Inc. | $5.35M | 1.22% | 0.12% | New | Q4 2025 |
| $5.3M | 1.21% | 0.29% | +19.6% | Q3 2025 | |
| $5.05M | 1.15% | 0.02% | -0.9% | Q2 2025 | |
| $5.03M | 1.15% | 0.00% | -0.9% | Q2 2020 | |
| $4.74M | 1.08% | 0.52% | +4.0% | Q3 2025 | |
| $4.7M | 1.07% | 0.08% | -47.6% | Q1 2019 | |
| $3.48M | 0.79% | 0.03% | -33.0% | Q1 2025 | |
| $2.16M | 0.49% | 0.06% | New | Q4 2025 | |
| $2.15M | 0.49% | 0.12% | -44.8% | Q2 2021 | |
| $2.03M | 0.46% | 0.14% | Not reported | Q3 2025 | |
| Q3 2025Reported Oct 31, 202541 positions | |||||
| $31.9M | 7.91% | 0.02% | +36.1% | Q4 2020 | |
| $28.9M | 7.17% | 0.02% | +35.5% | Q2 2020 | |
| $27.1M | 6.71% | 0.01% | +59.7% | Q1 2016 | |
| $26.2M | 6.50% | 0.03% | +43.2% | Q2 2014 | |
| $20.4M | 5.05% | 0.04% | +11.1% | Q4 2020 | |
| $17.7M | 4.40% | 0.17% | -5.2% | Q4 2017 | |
| $17.4M | 4.31% | 0.10% | +0.6% | Q3 2018 | |
| $17.3M | 4.30% | 0.01% | +39.7% | Q2 2024 | |
| $16.3M | 4.05% | 0.01% | +15.9% | Q3 2016 | |
| $11.8M | 2.92% | 0.01% | -4.2% | Q4 2018 | |
| $11.2M | 2.77% | 0.06% | +28.0% | Q1 2022 | |
| $10.6M | 2.62% | 0.05% | +49.1% | Q4 2013 | |
| $9.52M | 2.36% | 0.09% | +43.7% | Q4 2019 | |
| $9.34M | 2.32% | 0.02% | -9.8% | Q2 2013 | |
| $8.95M | 2.22% | 0.00% | -27.7% | Q2 2013 | |
| $8.69M | 2.15% | 0.07% | +42.4% | Q2 2013 | |
| $8.37M | 2.07% | 0.02% | +50.5% | Q2 2023 | |
| $8.15M | 2.02% | 0.17% | +28.0% | Q2 2019 | |
| $7.61M | 1.89% | 0.04% | +40.3% | Q4 2020 | |
| $7.45M | 1.85% | 0.03% | +33.3% | Q2 2025 | |
| $7.25M | 1.80% | 0.15% | +28.0% | Q1 2019 | |
| $6.62M | 1.64% | 0.06% | Not reported | Q1 2024 | |
| $6.4M | 1.59% | 0.08% | +28.0% | Q2 2013 | |
| $6.23M | 1.54% | 0.02% | +1.9% | Q2 2019 | |
| $6.19M | 1.53% | 0.06% | +5.2% | Q1 2019 | |
| $5.95M | 1.48% | 0.07% | +28.0% | Q2 2025 | |
| $5.81M | 1.44% | 0.21% | Not reported | Q2 2021 | |
| $5.68M | 1.41% | 0.01% | +73.8% | Q3 2013 | |
| $5.17M | 1.28% | 0.02% | +53.6% | Q2 2025 | |
| $4.84M | 1.20% | 0.04% | +43.1% | Q1 2025 | |
| $4.64M | 1.15% | 0.00% | +36.0% | Q2 2020 | |
| $4.37M | 1.08% | 0.03% | New | Q3 2025 | |
| $4.33M | 1.07% | 0.03% | +55.9% | Q1 2025 | |
| $3.88M | 0.96% | 0.50% | New | Q3 2025 | |
| $3.3M | 0.82% | 0.09% | +28.0% | Q2 2023 | |
| $3.27M | 0.81% | 0.40% | +28.0% | Q1 2025 | |
| $3.24M | 0.80% | 0.24% | New | Q3 2025 | |
| $3.1M | 0.77% | 0.00% | -48.9% | Q2 2016 | |
| $2.82M | 0.70% | 0.14% | New | Q3 2025 | |
| $2.73M | 0.68% | 0.01% | -26.0% | Q1 2021 | |
| AACLXArcellx, Inc. | $2.63M | 0.65% | 0.06% | +28.0% | Q1 2025 |
Premium opens every quarter this fund has filed